Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants
<p>Abstract</p> <p>Background</p> <p>An 11-valent pneumococcal conjugate vaccine could provide significantly larger reduction in pneumococcal disease burden than the currently available 7-valent vaccine formulation in many countries.</p> <p>Methods</p>...
Main Authors: | Käyhty Helena, Gepanayao Connie P, Puumalainen Taneli, Capeding Maria Z, Lucero Marilla G, Nohynek Hanna |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-08-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/3/17 |
Similar Items
-
Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
by: Ammar Hussam
Published: (2011-10-01) -
Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
by: Sung-Hsi Wei, et al.
Published: (2011-02-01) -
Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
by: Anne Marit de Groot, et al.
Published: (2017-12-01) -
Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults
by: Joon Young Song, et al.
Published: (2018-12-01) -
Myocarditis following diphtheria, whole-cell pertussis, and tetanus toxoid vaccination in a young infant
by: Vivek Kumar, et al.
Published: (2018-01-01)